D

Devonian Health Group Inc.

DHGRFiled

Devonian Health Group Inc. · NYSE American · latest filing 2026-09-02

Report source
One-minute decisionBASIC RESEARCHSource completeness · 78%

IPO research

Devonian is pursuing a proposed NYSE American firm-commitment offering of up to 3,070,000 units at an assumed USD 7.00 per unit, but the offering remains preliminary and depends on NYSE American approval. The issuer has continuing losses, substantial clinical and regulatory execution risk, and material dilution exposure.

Devonian Health Group Inc. filed an F-1/A for a proposed offering of up to 3,070,000 common units or pre-funded units, with NYSE American listing approval still pending.

Where does the money go?Awaiting verificationF-1/A · 2026-09-02
Ownership and votingAwaiting verified holder data— economic · — voting
Next disclosed checkpointEffectiveness of the registration statement and NYSE American decision on the proposed listing; pricing and closing dates are not supplied.F-1/A · 2026-09-02

Capital destination

Awaiting verification

F-1/A · 2026-09-02

Share-type percentages are not net-proceeds percentages. Amounts retain their stated gross/net basis; do not add unlike bases.

Check the source · F-1/A ↗
Next checkEffectiveness of the registration statement and NYSE American decision on the proposed listing; pricing and closing dates are not supplied.
Latest filing2026-09-02

Capital destination

Awaiting verification

F-1/A · 2026-09-02

Share-type percentages are not net-proceeds percentages. Amounts retain their stated gross/net basis; do not add unlike bases.

Check the source · F-1/A ↗
BOOKRUNNERS / LEAD UNDERWRITERSBookrunners / lead underwriters
NOT YET DISCLOSED

Names not yet published

Fully diluted valuation bridge

StatusReference
Awaiting verificationSource ↗

Basic-price scenario

A verified single offer price and basic post-offer share count are required. This is a data gap, not a paid lock.

Check the source · F-1/A ↗

Holder data awaits verification

Before the offering, CEO André P. Boulet beneficially owns 13.88%; all directors and executive officers as a group own 21.84%. Post-offering group ownership is stated at 10.38%. · 2026-09-02

Before the offering, CEO André P. Boulet beneficially owns 13.88%; all directors and executive officers as a group own 21.84%. Post-offering group ownership is stated at 10.38%.

One disclosed holder; not a complete ownership distribution.Check the source · F-1/A ↗

Conditional lock-up timeline

StatusReference
Awaiting verificationSource ↗

Financial quality and runway

StatusReference
Awaiting verificationSource ↗

Latest filing update

Loading saved filing update…

SEC filing history

Loading filing history…

SEC EDGAR

F-1/A

2026-09-02

Open SEC filing ↗